CCL5/CCR5-mediated peripheral inflammation exacerbates blood‒brain barrier disruption after intracerebral hemorrhage in mice.
Jie LinYa XuPeiwen GuoYù-Jié ChenJiru ZhouMin XiaBinbin TanXin LiuHua FengYu-Jie ChenPublished in: Journal of translational medicine (2023)
CCR5 might be a potential target for the clinical treatment of infection-induced exacerbation of BBB disruption following ICH.